The PiPS (Probiotics in Preterm Infants Study) Trial - Controlling the Confounding Factor of Cross-contamination Unveils Significant Benefits. | Indian Pediatr;54(2): 162, 2017 02 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The PiPS (Probiotics in Preterm Infants Study) Trial - Controlling the Confounding Factor of Cross-contamination Unveils Significant Benefits.

Karthikeyan, G; Bhat, B Vishnu.

Affiliation

Karthikeyan G; Departments of *Pediatrics, Karuna Medical College, Palakkad; and #Neonatology, JIPMER, Pondicherry; India. drgkarthikeyan@yahoo.co.uk.

Indian Pediatr ; 54(2): 162, 2017 02 15.

Article in En | MEDLINE | ID: mdl-28285299

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Probiotics / Enterocolitis, Necrotizing Limits: Humans / Infant / Newborn Language: En Journal: Indian Pediatr Year: 2017 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Probiotics / Enterocolitis, Necrotizing Limits: Humans / Infant / Newborn Language: En Journal: Indian Pediatr Year: 2017 Document type: Article